1. Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
   Weimin Xie et al, 2017, Oncotarget CrossRef
2. Induction of Oxidative Stress: A Promising Approach in Female Gynecological Cancer Therapeutic Arsenal
   Cornelia Amalinei et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
3. A triple-drug combination induces apoptosis in cervical cancer-derived cell lines
   Izamary Delgado-Waldo et al, 2023, Frontiers in Oncology CrossRef
4. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets
   Malgorzata Tyszka-Czochara et al, 2018, International Journal of Molecular Sciences CrossRef
5. Metformin in Cervical Cancer: Metabolic Reprogramming
   Malgorzata Tyszka-Czochara et al, 2019, Metformin [Working Title] CrossRef
6. A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma
   John P. Micha et al, 2023, Journal of Gynecologic Oncology CrossRef
7. Molecular and Cellular Mechanisms of Metformin in Cervical Cancer
   Ya-Hui Chen et al, 2021, Cancers CrossRef
8. Protective and therapeutic effects of metformin on gynecologic cancers
   Jee Young Hwang, 2016, Journal of Gynecologic Oncology CrossRef
9. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines
   Malgorzata Tyszka-Czochara et al, 2018, Nutrients CrossRef
10. Multidimensional effects of metformin in patients with type 2 diabetes
    Lyudmila A. Ruyatkina et al, 2017, Diabetes mellitus CrossRef
11. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer
    Shan-Bing Wang et al, 2017, Medicine CrossRef
12. Wastewater analysis reveals spatial pattern in consumption of anti-diabetes drug metformin in China
    Ji-Hao Yan et al, 2019, Chemosphere CrossRef
13. Metformin as a Therapeutic Target in Endometrial Cancers
    Teresa Y. Lee et al, 2018, Frontiers in Oncology CrossRef
14. Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
    Hyun Min Kim et al, 2022, Endocrinology and Metabolism CrossRef
15. Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma
    Miao Dai et al, 2017, Scientific Reports CrossRef
16. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
    Siddhartha Dutta et al, 2023, Drug Design, Development and Therapy CrossRef
17. Why Metformin Is so Important for Prevention and Therapy in Climacteric Women
    Justyna Kuliczkowska-Plaksej et al, 2018, Pre-Menopause, Menopause and Beyond CrossRef
18. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibitingNF-κBgene transcription
    Wei Wu et al, 2016, World Journal of Hepatology CrossRef
19. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
    Reetta Arima et al, 2017, Gynecologic Oncology CrossRef
20. Induction of Oxidative Stress: A Promising Approach in Female Gynecological Cancer Therapeutic Arsenal
    Cornelia Amalinei et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef